{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:15:15Z","timestamp":1786986915139,"version":"build-2736575974"},"reference-count":27,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100012781","name":"MSD K.K.","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019757","name":"Gloria Borges WunderGlo Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019757","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30CA014089"],"award-info":[{"award-number":["P30CA014089"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006508","name":"Dhont Family Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006508","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinical-colorectal-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Colorectal Cancer"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.clcc.2018.08.002","type":"journal-article","created":{"date-parts":[[2018,8,23]],"date-time":"2018-08-23T05:29:30Z","timestamp":1535002170000},"page":"e741-e749","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Immune-related Genes to Dominate Neutrophil-lymphocyte Ratio (NLR) Associated With Survival of Cetuximab Treatment in Metastatic Colorectal Cancer"],"prefix":"10.1016","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0163-7543","authenticated-orcid":false,"given":"Yu","family":"Sunakawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongyun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriana","family":"Moran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie H.","family":"Astrow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9180-2599","authenticated-orcid":false,"given":"Jack","family":"Hsiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig","family":"Stephens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihito","family":"Tsuji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takehiro","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Tanioka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Negoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akinori","family":"Takagane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Tani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8454-1995","authenticated-orcid":false,"given":"Tatsuro","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Eto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wataru","family":"Ichikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heinz-Josef","family":"Lenz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clcc.2018.08.002_bib1","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature01322","article-title":"Inflammation and cancer","volume":"420","author":"Coussens","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.clcc.2018.08.002_bib2","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/35077246","article-title":"Progress in human tumour immunology and immunotherapy","volume":"411","author":"Rosenberg","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.clcc.2018.08.002_bib3","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/bjc.2015.61","article-title":"Cytokine profile and prognostic significance of high neutrophil-lymphocyte ratio in colorectal cancer","volume":"112","author":"Chen","year":"2015","journal-title":"Br J Cancer"},{"key":"10.1016\/j.clcc.2018.08.002_bib4","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1002\/ijc.28536","article-title":"Prognostic role of neutrophil-to-lymphocyte ratio in colorectal cancer: a systematic review and meta-analysis","volume":"134","author":"Li","year":"2014","journal-title":"Int J Cancer"},{"key":"10.1016\/j.clcc.2018.08.002_bib5","doi-asserted-by":"crossref","first-page":"57516","DOI":"10.18632\/oncotarget.15497","volume":"8","author":"Zhang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.clcc.2018.08.002_bib6","first-page":"264","article-title":"Are markers of systemic inflammation good prognostic indicators in colorectal cancer?","volume":"16","author":"Rossi","year":"2017","journal-title":"Clin Colorectal Cancer"},{"key":"10.1016\/j.clcc.2018.08.002_bib7","doi-asserted-by":"crossref","first-page":"149","DOI":"10.2217\/fon.09.136","article-title":"Role of systemic inflammatory response in predicting survival in patients with primary operable cancer","volume":"6","author":"Roxburgh","year":"2010","journal-title":"Future Oncol"},{"key":"10.1016\/j.clcc.2018.08.002_bib8","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1038\/bjc.2011.100","article-title":"Neutrophil\/lymphocyte ratio predicts chemotherapy outcomes in patients with advanced colorectal cancer","volume":"104","author":"Chua","year":"2011","journal-title":"Br J Cancer"},{"key":"10.1016\/j.clcc.2018.08.002_bib9","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/ajco.12784","article-title":"Clinical significance of changes in systemic inflammatory markers and carcinoembryonic antigen levels in predicting metastatic colorectal cancer prognosis and chemotherapy response","volume":"14","author":"Kim","year":"2018","journal-title":"Asia Pac J Clin Oncol"},{"key":"10.1016\/j.clcc.2018.08.002_bib10","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ejso.2007.02.014","article-title":"Elevated preoperative neutrophil to lymphocyte ratio predicts survival following hepatic resection for colorectal liver metastases","volume":"34","author":"Halazun","year":"2008","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.clcc.2018.08.002_bib11","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/jso.21294","article-title":"Systemic inflammatory response predicts postoperative outcome in patients with liver metastases from colorectal cancer","volume":"100","author":"Ishizuka","year":"2009","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.clcc.2018.08.002_bib12","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1186\/s12885-017-3752-0","article-title":"The preoperative neutrophil to lymphocyte ratio is a superior indicator of prognosis compared with other inflammatory biomarkers in resectable colorectal cancer","volume":"17","author":"Song","year":"2017","journal-title":"BMC Cancer"},{"key":"10.1016\/j.clcc.2018.08.002_bib13","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s12032-014-0166-6","article-title":"Systemic inflammation, as measured by the neutrophil\/lymphocyte ratio, may have differential prognostic impact before and during treatment with fluorouracil, irinotecan and bevacizumab in metastatic colorectal cancer patients","volume":"31","author":"Formica","year":"2014","journal-title":"Med Oncol"},{"key":"10.1016\/j.clcc.2018.08.002_bib14","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1093\/annonc\/mdy004","article-title":"Prognostic and predictive role of neutrophil\/lymphocytes ratio in metastatic colorectal cancer: a retrospective analysis of the TRIBE study by GONO","volume":"29","author":"Dell\u2019Aquila","year":"2018","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clcc.2018.08.002_bib15","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1093\/jnci\/djy088","article-title":"Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): an abridged explanation and elaboration","volume":"110","author":"Sauerbrei","year":"2018","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.clcc.2018.08.002_bib16","doi-asserted-by":"crossref","first-page":"4781","DOI":"10.7314\/APJCP.2014.15.12.4781","article-title":"Treatment of metastatic colorectal cancer with or without bevacizumab: can the neutrophil\/lymphocyte ratio predict the efficiency of bevacizumab?","volume":"15","author":"Dirican","year":"2014","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1016\/j.clcc.2018.08.002_bib17","doi-asserted-by":"crossref","first-page":"17166","DOI":"10.1038\/s41598-017-17130-6","article-title":"Pre-treatment inflammatory indexes as predictors of survival and cetuximab efficacy in metastatic colorectal cancer patients with wild-type RAS","volume":"7","author":"Yang","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.clcc.2018.08.002_bib18","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1245\/s10434-008-0267-6","article-title":"Blood neutrophil-to-lymphocyte ratio predicts survival in patients with colorectal liver metastases treated with systemic chemotherapy","volume":"16","author":"Kishi","year":"2009","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clcc.2018.08.002_bib19","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1007\/s00384-012-1459-x","article-title":"Can neutrophil-to-lymphocyte ratio predict the survival of colorectal cancer patients who have received curative surgery electively?","volume":"27","author":"Chiang","year":"2012","journal-title":"Int J Colorectal Dis"},{"key":"10.1016\/j.clcc.2018.08.002_bib20","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1159\/000441396","article-title":"Prognostic impact of neutrophil-to-lymphocyte ratio in patients with advanced low rectal cancer treated with preoperative chemoradiotherapy","volume":"32","author":"Nagasaki","year":"2015","journal-title":"Dig Surg"},{"key":"10.1016\/j.clcc.2018.08.002_bib21","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/bjc.2016.23","article-title":"Derived neutrophil lymphocyte ratio is\u00a0predictive of survival from intermittent therapy in advanced colorectal cancer: a post hoc analysis of the MRC COIN study","volume":"114","author":"Grenader","year":"2016","journal-title":"Br J Cancer"},{"key":"10.1016\/j.clcc.2018.08.002_bib22","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1007\/s00384-014-1964-1","article-title":"Impact of the perioperative neutrophil-to-lymphocyte ratio on the long-term survival following an elective resection of colorectal carcinoma","volume":"29","author":"Kubo","year":"2014","journal-title":"Int J Colorectal Dis"},{"key":"10.1016\/j.clcc.2018.08.002_bib23","doi-asserted-by":"crossref","first-page":"11591","DOI":"10.1200\/JCO.2016.34.15_suppl.11591","article-title":"Immune-related genes to predict clinical outcome of cetuximab (cet) treatment for metastatic colorectal cancer (mCRC): immuno-Oncology assay research","volume":"34","author":"Sunakawa","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clcc.2018.08.002_bib24","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1073\/pnas.92.4.998","article-title":"Thymidine phosphorylase is angiogenic and promotes tumor growth","volume":"92","author":"Moghaddam","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.clcc.2018.08.002_bib25","first-page":"1329","article-title":"N-myc downstream regulated gene 1 (NDRG1)\/Cap43 enhances portal vein invasion and intrahepatic metastasis in human hepatocellular carcinoma","volume":"20","author":"Akiba","year":"2008","journal-title":"Oncol Rep"},{"key":"10.1016\/j.clcc.2018.08.002_bib26","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1158\/1078-0432.CCR-08-1119","article-title":"A\u00a0TaqMan low-density array to predict outcome in advanced Hodgkin\u2019s lymphoma using paraffin-embedded samples","volume":"15","author":"Sanchez-Espiridion","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.clcc.2018.08.002_bib27","doi-asserted-by":"crossref","first-page":"e80908","DOI":"10.1371\/journal.pone.0080908","article-title":"Macrophage polarisation: an immunohistochemical approach for identifying M1 and M2 macrophages","volume":"8","author":"Barros","year":"2013","journal-title":"PLoS One"}],"container-title":["Clinical Colorectal Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1533002818303530?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1533002818303530?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T23:04:55Z","timestamp":1761519895000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1533002818303530"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["S1533002818303530"],"URL":"https:\/\/doi.org\/10.1016\/j.clcc.2018.08.002","relation":{},"ISSN":["1533-0028"],"issn-type":[{"value":"1533-0028","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immune-related Genes to Dominate Neutrophil-lymphocyte Ratio (NLR) Associated With Survival of Cetuximab Treatment in Metastatic Colorectal Cancer","name":"articletitle","label":"Article Title"},{"value":"Clinical Colorectal Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clcc.2018.08.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}